Zac Ezzone is a journalist based in Charlotte, North Carolina. He writes for the Charlotte Business Journal, covering local business news and developments in the Charlotte area. His work has also been featured in Yahoo Finance.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Raleigh, United States (Local)
Not enough data
Zac Ezzone's coverage largely revolves around local business and healthcare, with a focus on private sector announcements and expert commentary. This suggests he would be most receptive to pitches that provide unique insights into the local business landscape, particularly in North Carolina and Charlotte.
Given his emphasis on expert commentary, Zac may find value in pitches offering exclusive interviews or opinions from industry leaders within the biotechnology, pharmaceuticals, and healthcare sectors operating within the North Carolina area.
Considering his interest in private sector announcements, Zac might also respond well to press releases or pitches related to significant developments within companies based in North Carolina or those impacting the local business environment.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Faces to Watch in 2025: New CEO steers clinical research giant
By: Zac Ezzone
A long career in drug development led Peyton Howell to her biggest role yet.
By: Zac Ezzone
An investment firm led by executives with ties to the Triangle has acquired a Durham company.
By: Zac Ezzone
What started has a potential $900 million deal has turned into an acquisition for a Durham company.
By: Zac Ezzone
After years of crafting policy as an elected official, Josh Dobson is now leading the top hospital lobbying group in North Carolina
By: Zac Ezzone
Major investors are betting that a Durham company has a potential cure for hepatitis B.
By: Zac Ezzone
The company says it no longer plans to meet its hiring goals in the Triangle.
By: Zac Ezzone
What started has a potential $900 million deal has turned into an acquisition for a Durham company.
Relias expands reach with acquisition of Raleigh firm
By: Zac Ezzone
A Durham biotechnology firm with ties to UNC has a new CEO.
(833) 317-6278 